DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
RSQCX
Price
$15.99
Change
-$0.06 (-0.37%)
Updated
Jul 31 closing price
Net Assets
494.75M
Interact to see
Advertisement

DFSVX vs RSQCX

DFSVX vs RSQCX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. RSQCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and RSQCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. RSQCX (495M). DFSVX pays higher dividends than RSQCX: DFSVX (1.50) vs RSQCX (1.24). DFSVX was incepted earlier than RSQCX: DFSVX (33 years) vs RSQCX (23 years). RSQCX (2.45) is less costly to investors than DFSVX (0.31). RSQCX is a more actively managed with annual turnover of: 12.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than RSQCX: DFSVX (0) vs RSQCX (2000). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. RSQCX (25.95). DFSVX return over 5 years is better than : 50.66 vs. RSQCX (-11.07).
DFSVXRSQCXDFSVX / RSQCX
Total Expense Ratio0.312.2414%
Annual Report Gross Expense Ratio0.312.4513%
Fund Existence33 years23 years-
Gain YTD21.33626.00582%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B495M3,939%
Annual Yield % from dividends1.501.24121%
Returns for 1 year34.3925.95133%
Returns for 3 years50.375.25960%
Returns for 5 years50.66-11.07-458%
Returns for 10 years107.71-8.14-1,323%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I